Caldwell Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Caldwell Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$95K	Sell	600 -60	-9%	-$8.11K	0.01%	416
2026 Q1	$84.3K	Hold	660	–	–	0.01%	426
2025 Q4	$80.5K	Hold	660	–	–	0.01%	417
2025 Q3	$66.1K	Hold	660	–	–	0.01%	435
2025 Q2	$54.7K	Hold	660	–	–	0.01%	452
2025 Q1	$53.5K	Hold	660	–	–	0.01%	457
2024 Q4	$59.4K	Hold	660	–	–	0.01%	441
2024 Q3	$65.2K	Hold	660	–	–	0.01%	431
2024 Q2	$61.2K	Sell	660 -55	-8%	-$4.93K	0.01%	433
2024 Q1	$67.8K	Hold	715	–	–	0.01%	423
2023 Q4	$63.8K	Sell	715 -405	-36%	-$30.1K	0.01%	417
2023 Q3	$81.8K	Hold	1,120	–	–	0.01%	374
2023 Q2	$93.2K	Hold	1,120	–	–	0.01%	365
2023 Q1	$85.4K	Hold	1,120	–	–	0.01%	365
2022 Q4	$93K	Sell	1,120 -150	-12%	-$12.1K	0.01%	350
2022 Q3	$101K	Sell	1,270 -20	-2%	-$1.69K	0.02%	343
2022 Q2	$95.8K	Hold	1,290	–	–	0.01%	359
2022 Q1	$116K	Sell	1,290 -100	-7%	-$9.23K	0.01%	351
2021 Q4	$156K	Hold	1,390	–	–	0.02%	318
2021 Q3	$175K	Sell	1,390 -150	-10%	-$19.3K	0.02%	293
2021 Q2	$209K	Buy	1,540 +20	+1%	+$2.63K	0.03%	272
2021 Q1	$206K	Hold	1,520	–	–	0.03%	267
2020 Q4	$214K	Hold	1,520	–	–	0.03%	248
2020 Q3	$169K	Buy	1,520 +160	+12%	+$17.9K	0.03%	264
2020 Q2	$152K	Buy	1,360 +20	+1%	+$1.97K	0.03%	276
2020 Q1	$104K	Buy	1,340 +300	+29%	+$26.6K	0.02%	317
2019 Q4	$98.9K	Buy	+1,040	New	+$90K	0.02%	364

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Caldwell Trust's XBI Position: Q2 2026 in Review

Caldwell Trust reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 9.1% in Q2 2026, selling an estimated $8.11K and leaving 600 shares worth $95K. The position accounts for 0.01% of the portfolio, ranked #416.

Caldwell Trust first reported a position in XBI in Q4 2019 and has held it in 27 quarters since. The position peaked at $214K in Q4 2020. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Caldwell Trust held 600 shares of State Street SPDR S&P Biotech ETF worth $95K as of Q2 2026.
Caldwell Trust sold 60 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $8.11K.
State Street SPDR S&P Biotech ETF made up 0.01% of Caldwell Trust's portfolio in Q2 2026, its #416 holding.
Caldwell Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 27 quarters since.
Caldwell Trust's State Street SPDR S&P Biotech ETF position peaked at $214K in Q4 2020.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.